SCHEMBL4479045

SCHEMBL4479045

Cc1cc(NC(=O)C(C)(C)NC(=O)c2ccc(Br)s2)ccc1N1C(=S)CCC1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.52
F10 P00742 4/20 0.51
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
NFKB1 P19838 3/20 0.39
NFKB2 Q00653 3/20 0.39
RELA Q04206 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
CASP3 P42574 2/20 0.39
SENP7 Q9BQF6 2/20 0.39
POLB P06746 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
MAPT P10636 5/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TP53 P04637 3/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6462262 0.88 F10 (0.57) ARF10MEN1KMT2ANPC1
SCHEMBL4465296 0.83 F10 (0.55) ARF10MEN1KMT2ANPC1
SCHEMBL4461797 0.82 F10 (0.55) ARF10MEN1KMT2ANPC1
SCHEMBL4475088 0.82 F10 (0.55) ARF10MEN1KMT2ANPC1
SCHEMBL5511036 0.81 NPY2R (0.37) F10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL4467642 0.80 F10 (0.54) ARF10MEN1KMT2ANPC1
SCHEMBL4459934 0.79 F10 (0.53) ARF10MEN1KMT2ANPC1
SCHEMBL4465502 0.79 F10 (0.69) ARF10
SCHEMBL4463968 0.79 F10 (0.53) ARF10MEN1KMT2ANPC1
SCHEMBL4463490 0.79 F10 (0.58) ARF10MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476663-B2 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-13 US disclosed
US-20050277628-A1 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277628-A1 Substituted thiophene carboxamides OTC, SLC22A8, DDC AR 2088/4885F10 2132/4885MEN1 2017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.